Avelumab, CAS [[1537032-82-8]]

Artikelnummer: MCE-HY-108730
Artikelname: Avelumab, CAS [[1537032-82-8]]
Artikelnummer: MCE-HY-108730
Hersteller Artikelnummer: HY-108730
Alternativnummer: MCE-HY-108730-25MG,MCE-HY-108730-1MG,MCE-HY-108730-5MG,MCE-HY-108730-10MG
Hersteller: MedchemExpress
Kategorie: Antikörper
Alternative Synonym: Anti-Human PD-L1, Human Antibody, MSB 0010718C, MSB0010718C
Avelumab (Anti-Human PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab can be used for the study of chordoma[1].
Molekulargewicht: (150 kDa)
Reinheit: 99.30
CAS Nummer: [1537032-82-8]
Target-Kategorie: PD-1/PD-L1
Anwendungsbeschreibung: Inhibitory Antibodies